Navigation Links
No racial differences seen in outcomes after liver transplantation
Date:11/1/2007

Minority patients do not necessarily have worse outcomes after liver transplantation. When treated at the same medical centers as Caucasians, they fare just as well. These are the results of a new study in the November issue of Hepatology, a journal published by John Wiley & Sons on behalf of the American Association for the Study of Liver Diseases (AASLD). The article is also available online at Wiley Interscience (http://www.interscience.wiley.com/journal/hepatology).

While some studies have shown that minority patients who undergo liver transplantation have outcomes similar to those of Caucasian patients, many others have revealed discrepancies based on race. A recent nationwide study of all transplant patients found that African American and Asian race were independent risk factors for poorer outcomes, however, that study did not consider the hospital or region where the transplantation was performed.

To address the possibility that discrepancies in outcomes could be explained by access (or lack of it) to the best transplant centers, researchers, led by W. Ray Kim of the Mayo Clinic, considered racial differences in survival after liver transplantation using only data from selected high volume academic liver transplant centers.

They examined data from two NIH sponsored multi-center liver transplant databases: the National Institute of Diabetes and Digestive and Kidney Disease Liver Transplantation Database, and the MELD Study Group Database. The study population included 2823 adult patients who underwent liver transplantation at the Mayo Clinic, the University of California San Francisco, the University of Nebraska, and Baylor University. Of the patients, 2448 were Caucasian, 135 were African America, and 240 were of another race, including Asian and Hispanic. The researchers analyzed the data, considering demographic, clinical and laboratory factors.

Although there were noticeable differences in baseline characteristics,
'/>"/>

Contact: Amy Molnar
amolnar@wiley.com
John Wiley & Sons, Inc.
Source:Eurekalert

Page: 1 2

Related medicine news :

1. Death Wishes Influenced By Ethnicity and Racial Background
2. Racial Identity Dictates What We See Or Rather Whom We See
3. Racial disparities in cancer patients in U.S.
4. Racial differences show difference in blood sugar control too!!
5. Medicare Marked by Widespread Racial disparities
6. Racial Gap in Floridas Infant Mortality Rates Increasing
7. Risk of Birth Complications Varies Between Racial Groups
8. More Evidence of Racial Discrimination in the NHS
9. Social Factors Not Genetics Drive Racial Disparities in Colorectal Cancer Survival
10. Racial Discrimination Takes The Nobility Out Of Doctoring
11. Genetic differences found between Male and Female brains
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/8/2009)...it lowered bad cholesterol more effectively than Z...s) -- After nearly a year of review, U.S. health o...tinued use of the controversial cholesterol-loweri...istration said there was no significant difference...ng Vytorin and patients taking the drug Zocor. ,...
(Date:1/8/2009)... of local dance students will dance to raise money...POLIS, Jan. 8 , , , WHO: ...ll show off their talent in the 3rd annual Dance,...y Dance Arts Centre. The, event w...or., Participants raise money th...
(Date:1/8/2009)...AGO, Jan. 8 Allscripts-M...pts Healthcare Solutions, Inc. (Allscripts or,the...or the three and six,months ended November 30, 20...n/prnh/20061005/ALLSCRIPTSLOGO-b ) , The Co... November 30, 2008,include results from legacy Al...
(Date:1/8/2009)...FRANCISCO, Jan. 8 Mediva... David Hung, M.D., president and chief,executive ...an Healthcare,Conference on Wednesday, January 14...ancis Hotel in San Francisco. , Dr. Hung wi...cal,development programs for Dimebon for Alzheime...
Breaking Medicine News(10 mins):Health News:FDA Backs Cholesterol Drug Vytorin 2Health News:Dance With Courage to Benefit Camp Courage 2Health News:Allscripts Reports Fiscal 2009 Second Quarter Results 2Health News:Allscripts Reports Fiscal 2009 Second Quarter Results 3Health News:Allscripts Reports Fiscal 2009 Second Quarter Results 4Health News:Allscripts Reports Fiscal 2009 Second Quarter Results 5Health News:Allscripts Reports Fiscal 2009 Second Quarter Results 6Health News:Allscripts Reports Fiscal 2009 Second Quarter Results 7Health News:Allscripts Reports Fiscal 2009 Second Quarter Results 8Health News:Allscripts Reports Fiscal 2009 Second Quarter Results 9Health News:Allscripts Reports Fiscal 2009 Second Quarter Results 10Health News:Allscripts Reports Fiscal 2009 Second Quarter Results 11Health News:Allscripts Reports Fiscal 2009 Second Quarter Results 12Health News:Allscripts Reports Fiscal 2009 Second Quarter Results 13Health News:Medivation Announces Participation in 27th Annual J.P. Morgan Healthcare Conference 2
...ement has fuelled a booming industry and turned pl...than 22,000 operations were carried out on men and.... The number of women // opting for cosmetic surge...interest also increased, particularly for facial a...
...history of heart problems and consume anti-impoten...ng their eyesight damaged, according to a study co...chers suggest that taking viagra may result in the...ow, giving rise to tissue damage. The British Medi...
... increase in the incidence of Polio in Bihar state...tate health officials. The state stands unparalle... country. // A massive polio immunization programm...ildren less than 5 years of age has been launched ...
...lu pandemic is on the rise as there are new report...agglutinin antigen fragment of the bird flu virus ...e to antiflu drugs shown by these viruses. Scienti..., in which the antibodies is collected from the bl...
Other Medicine News:Health News:UK Plastic surgeons cash in as cosmetic operations soar 2Health News:UK Plastic surgeons cash in as cosmetic operations soar 3Health News:Bihar Health Officials Worried As Polio Cases Soar 2
(Date:1/7/2009)... , FREDERICK, Md., Jan. 7 ImQue...bmission of an IND application to the Food and Dru... for their lead pyrimidinedione HIV inhibitor IQP-... studies in the first quarter of 2009. IQP-0410 is...marily acts as a nonnucleoside reverse transcripta...
(Date:1/6/2009)... , Program Expands on Successful Results from p... Jan. 7 Vital Therapies, Inc. (VTI...ease, today announced patient enrollment has begun... 2 clinical trial that will study the Extracorpore...atients with Acute Liver Failure (ALF) under three...
(Date:1/6/2009)... , ROCKVILLE, Md., Jan. 6 /PRNewswire-USNewswir...utical company focused on diseases of epidemic pot...candidate for the treatment of tuberculosis (TB), ...wly awarded clinical program contract to Dynport V...e contract, awarded by the National Institute of A...
(Date:1/5/2009)... , SAN DIEGO, Jan. 5 Cylene Pha... a Phase I clinical trial of its oral CK2 protein ...ed solid tumors, Castleman,s disease, or multiple ...calating trial are determination of safety, tolera... appropriate dose for Phase II trials. In addition...
Breaking Medicine Technology:ImQuest Submits Investigational New Product Application to the Food and Drug Administration to Initiate HIV Therapeutic Clinical Trials with IQP-0410 2ELAD(R) Liver Support System Study Initiated at Multiple U.S. Centers 2ELAD(R) Liver Support System Study Initiated at Multiple U.S. Centers 3Sequella Lead Drug Compound SQ109 Selected for Phase 1B Clinical Trial Program 2Sequella Lead Drug Compound SQ109 Selected for Phase 1B Clinical Trial Program 3Cylene Pharmaceuticals Initiates Phase I Trial With CX-4945 -Breakthrough First-in Class Inhibitor of CK2 2Cylene Pharmaceuticals Initiates Phase I Trial With CX-4945 -Breakthrough First-in Class Inhibitor of CK2 3Greenway Medical Technologies EHR Solution PrimeSuite Wins Three Best in KLAS Awards 32167 1Greenway Medical Technologies EHR Solution PrimeSuite Wins Three Best in KLAS Awards 32167 2Greenway Medical Technologies EHR Solution PrimeSuite Wins Three Best in KLAS Awards 32167 3Greenway Medical Technologies EHR Solution PrimeSuite Wins Three Best in KLAS Awards 32167 4Sage Software Healthcare Appoints Kathleen Henry Senior Vice President Customer Service 32165 1Sage Software Healthcare Appoints Kathleen Henry Senior Vice President Customer Service 32165 2Immune System Works Better at Night 32164 1Immune System Works Better at Night 32164 2Later School Start Time Cuts Teens Car Crash Risk 32162 1Later School Start Time Cuts Teens Car Crash Risk 32162 2Later School Start Time Cuts Teens Car Crash Risk 32162 3
...)--Jun 4, 2007 - Introgen Therapeutics, Inc.,(NASD... today,reported updated Phase 2 data demonstrating...umor responses and increased,survival following AD...us cell carcinoma of the head and neck. The data (... meeting of the American,Society of Clinical Oncol...
...se 2 Clinical Data Published at the American,Socie...GO, June 04, 2007 /PRNewswire-FirstCall/ -- Pharmi...m its Phase II,multi-center clinical study of Amr...nthracycline currently in development,for the trea...dicate favorable interim results in terms of respo...
Other Medicine Technology:Introgen Reports Updated Phase 2 Advexin Data Correlating Improved,Survival, Tumor Responses and Predictive p53 Biomarker 2Introgen Reports Updated Phase 2 Advexin Data Correlating Improved,Survival, Tumor Responses and Predictive p53 Biomarker 3Introgen Reports Updated Phase 2 Advexin Data Correlating Improved,Survival, Tumor Responses and Predictive p53 Biomarker 4Pharmion's Amrubicin Shows Encouraging Results Compared to Standard,of Care in Second Line Treatment of Small Cell Lung Cancer 2Pharmion's Amrubicin Shows Encouraging Results Compared to Standard,of Care in Second Line Treatment of Small Cell Lung Cancer 3Pharmion's Amrubicin Shows Encouraging Results Compared to Standard,of Care in Second Line Treatment of Small Cell Lung Cancer 4
The 15 and 18 Sony Flat Screen Monitors with articulating arm can be used in conjunction with existing surgical monitors or as replacements.
Colour video monitors.
The A3 3-Chip Camera includes digital processing, seamless autoshutter, industry-leading reliability, white balance with memory function, ease of operation, and a 2 year warranty.
Camera and light source in one compact "Plug-and-Play" device.
Medicine Products: